加拿大疫苗

[lindamy]

 

[lindamy]

 

[lindamy]

Federal government invests $200 million to build an mRNA vaccine plant in Ontario​ ​

​

Canada's reliance on vaccines developed or even produced in other countries has been a story well told throughout this coronavirus pandemic, and one the federal government hopes is not repeated for any global health crisis in the future. Innovation Minister François-Philippe Champagne announced a $200-million investment to upgrade existing facilities of Resilience Biotechnologies Inc. in Mississauga, Ont. The funds will expand Resilience's manufacturing and fill-finish capacity for a number of vaccines and therapeutics, including mRNA shots like the ones now being used to fight COVID-19, Champagne said. The dependence on foreign sources for shots has seen Canada contend with the threat of export controls and vaccine nationalism, which limited the supply of vaccine doses in the early weeks of the national inoculation campaign. As a result, the Liberal government has placed bets in a number of ways to try and alleviate that strain. "To rebuild from this pandemic, we're investing in Canada — in workers, in innovation and in the future," said Prime Minister Justin Trudeau. Last fall, the federal government floated $173 million to help Medicago of Quebec City develop its COVID-19 vaccine and build a large plant to produce it. Medicago, which is developing the product in combination with GlaxoSmithKline, has reported positive early clinical trial data on its plant-derived vaccine. In addition to the Resilience funding pledge and the Medicago commitment, the federal government has already promised some $455 million for a major expansion of Sanofi's Toronto plant, which will primarily produce flu shots but it can also be retooled to produce vaccines for coronaviruses. Once operational, Sanofi will be able to manufacture enough influenza vaccines for all Canadians each year at its Toronto facility. The government says the plant expansion for Resilience will create 500 permanent jobs and 50 co-op placements for students, once construction is complete in 2024.​

Read more about the announcement​

​

 

[lindamy]

加拿大疫苗至少一针的人口比例基本与美国持平，略低于英国。

 

[向问天]

浏览附件976748

加拿大疫苗至少一针的人口比例基本与美国持平，略低于英国。

中国呢？

 

[space_invader]

加拿大疫苗至少一针的人口比例基本与美国持平，略低于英国。

好消息！！我觉得加拿大最后会超过以色列。
谁知道为啥日本比例那么低？？

 

[lindamy]

中国呢？

中国只报总数，不分一针，两针。

 

[向问天]

好消息！！我觉得加拿大最后会超过以色列。
谁知道为啥日本比例那么低？？

听说日本要自己再做辉瑞第三期临床试验。

 

[lindamy]

 

[ottawa_tj]

Moderna疫苗可能会延期交货，会影响到第二针疫苗接种。。。

BC准备对那些高危人群，把两针间隔从16周减到8周，而且考虑混打（如果第一针辉瑞，第二针可以考虑Moderna）。

Delayed deliveries of Moderna’s COVID-19 vaccine complicate provincial rollout plans — Toronto Star

A vial of the Moderna COVID-19 vaccine, shown at the West Wales General Hospital in Carmarthen, Wales, on April 7, 2021.

apple.news

 

[lindamy]

加拿大至少一针人口比率排在世界前三名，完全的免疫的比率惨点，起码说明相信疫苗，参加疫苗免疫的人群比较多。

 

[lindamy]

 

[lindamy]

 

[lindamy]

At least 7 million Moderna doses will arrive before end of June, federal government says​ ​

​

Moderna will ship seven million more vaccine doses to Canada this month, ending weeks of uncertainty over when the Massachusetts-based company would deliver the long-promised order. Moderna has delivered 6.1 million doses to Canada already, but has routinely slashed deliveries or punted them to later dates since the beginning of the year, causing provincial and regional officials to be nimble in administering their vaccine campaigns. Starting next week, Public Services and Procurement Minister Anita Anand said Wednesday, the deliveries will start to stabilize. "To be clear, that is the minimum number of doses that we anticipate receiving in that timeframe," Anand said of the seven million. Moderna has earmarked all U.S. production of its doses for the American marketplace until now, with Canada's previous batches coming from their European facilities. But the U.S. is now awash in shots and demand for doses there is declining. So, for the first time, Moderna will be shipping its product to Canada from U.S.-based plants. "Moderna will continue working hard to help protect Canadians from COVID and its variants," a spokesperson said in a statement. Two days ago, the company said it had applied for emergency authorization use for its vaccine in adolescents after positive trial data. Should it get approved by Health Canada, Moderna would join Pfizer-BioNTech as the vaccines deemed suitable for use in Canadians as young as 12. Meanwhile, Anand said that between planned Pfizer-BioNTech, Moderna and AstraZeneca-Oxford vaccine shipments, a total of 55.8 million vaccine doses is expected to be delivered to Canada between now and the end of July.​

Read more details from the federal public health briefing​

 

[lindamy]